Intas Pharmaceuticals Ltd - Company Profile
Powered by 
All the sales intelligence you need on Intas Pharmaceuticals Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Intas Pharmaceuticals Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Intas Pharmaceuticals Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Intas Pharmaceuticals Ltd patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| EP4284336A1 | Application | Im mund dispergierbare feste pharmazeutische darreichungsform von rasagilin | A61K31/135; A61K47/26; A61K47/32; A61K47/38; A61K9/0002; A61K9/0056; A61K9/2027; A61K9/2095; A61P25/16 | December 06, 2023 |
| US11833253B1 | Grant | Extended release pharmaceutical composition of clozapine | A61K31/5513; A61K9/2077; A61K9/5015; A61K9/5047; A61K9/5073; A61K9/5192 | December 05, 2023 |
| EP4055005A4 | Search Report | Flüssige melphalanzusammensetzung | A61K31/198; A61K47/02; A61K47/10; A61K47/12; A61K47/20; A61K9/0019; A61K9/08; A61P35/00; C07C227/44 | November 29, 2023 |
| ZA202200331B | Grant | Naltrexone formulation | A61K31/485; A61K9/0056; A61K9/2013; A61K9/2018; A61K9/2054; A61K9/2059; A61P1/00; A61P1/04 | November 29, 2023 |
| ZA202200335B | Grant | Pharmaceutical composition of temozolomide. | A61K31/495; A61K47/02; A61K47/10; A61K47/12; A61K9/0095 | November 29, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer